The present invention discloses nucleic acid sequence which encodes
infectious hepatitis C virus of strain HC-J6.sub.CH, gentotype 2a, and
the use of the sequence, and polypeptides encoded by all or part of the
sequence, in the development of vaccines and diagnostics for HCV and in
the development of screening assays for the identification of antiviral
agents for HCV.